Literature DB >> 15039471

Warfarin resistance with poor CYP2C9 activity and CYP2C9*1*2 genotype.

Nese Dericioglu, Melih O Babaoglu, Serap Saygi, Atila Bozkurt, Umit Yasar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15039471     DOI： 10.1345/aph.1D450

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  2 in total

1.  The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements in an adult Turkish population.

Authors:  Nihat Ozer; Nese Cam; Burak Tangurek; Songul Ozer; Huseyin Uyarel; Dilaver Oz; Mehmet Rasit Guney; Figen Ciloglu
Journal:  Heart Vessels       Date:  2010-03-26       Impact factor: 2.037

2.  VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients.

Authors:  G Oner Ozgon; T Y Langaee; H Feng; N Buyru; T Ulutin; A C Hatemi; A Siva; S Saip; J A Johnson
Journal:  Eur J Clin Pharmacol       Date:  2008-06-10       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.